Replay available

Lucid Diagnostics Inc. (LUCD) Q2 2023 Earnings Call

Lucid Diagnostics Inc. (NASDAQ: LUCD) Q2 2023 earnings conference call, held 2023-08-15. Replay captured from the company's public earnings webcast.

Tue, August 15, 2023 at 8:30 AMendedReplay
Lucid Diagnostics Inc. (LUCD) Q2 2023 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Michael Parks

VP, Investor Relations

Dr. Leshawn Aklog

Chairman and CEO

Kyle Michlin

Analyst, Canaccord Genuity

Replay transcript excerpt

Good day and welcome to the Lucid Diagnostics second quarter 2023 business update conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on a touch phone. To withdraw your question, please press star then two. Please note, this event is being recorded. I would now like to turn the conference over to Michael Parks, VP, Investor Relations. Please go ahead. Thank you, Betsy. Good morning, everyone. Thank you for participating in today's second quarter 2023 business update call. The press release announcing our business update for the company and financial results for the three and six months ended June 30, 2023 is available on the Lucid website. Please take a moment to read the disclaimer about forward-looking statements in the press release. Business update, press release, and this conference call include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer in our filings with the U.S. Securities and Exchange Commission. For a list and description of these and other important risks and uncertainties that may affect future operations, see Part 1, Item 1A, entitled Risk Factors, and Lucid's most recent annual report on Form 10-Q filed with the SEC, and subsequent updates filed in quarterly reports on Form 10-Q and any subsequent Form 8-K filing. Except as required by law, Lucid disclaims any intentions or obligatio...

More from Lucid Diagnostics Inc.